For personal use only

Size: px
Start display at page:

Download "For personal use only"

Transcription

1 ASX Code: A2M NZX Code: ATM 20 July 2015 NZX/ASX Market Release Record Australian earnings, Exceptional a2 Platinum infant formula growth, Positive progress in international markets With regard to recent interest in The a2 Milk Company (the Company), the Company provides this trading update in relation to the current performance of the business and the outlook for the year ending June The financial information in this update has been prepared on the following basis: FY14 segment financials have been extracted from 30 June 2014 audited financial statements; FY15 financials have been sourced from unaudited management accounts for the 30 June 2015 financial year and remain subject to finalisation during the auditing process; and FY16 financials reflect the Company s budget for the June 2016 financial year with foreign exchange rates as at 30 June The Company considers that its budget has been prepared on a prudent basis and could reasonably expect performance to exceed budget projections if current trading conditions and trends in infant formula are sustained throughout the course of FY16. 1 Financial Summary The Company s growth initiatives continue to progress in a particularly pleasing manner, and the results of this progress are now evident in FY15 trading summarised below. The Australian and New Zealand (ANZ) business is performing strongly and continues to provide a platform for the Company s international growth initiatives. The underlying trading result for FY15 is ahead of plan with Group revenue of NZ$154 million (39% increase over the prior corresponding period (PCP)). Strong growth is expected to continue in FY16 with budgeted Group revenue of NZ$267 million (73% increase over PCP) and Group Operating EBITDA 2 of NZ$12 million (200% increase over PCP). The trend in geographic segment financial performance from FY14 (audited), through FY15 (unaudited), to FY16 (budget), is set out in the table below. 3 FY14 FY15 FY16 % Growth NZ$ million Actual Unaudited Budget FY14-15 FY15-16 Revenue ANZ % 45% China and Other Asia % UK and US % 1800% Group Revenue % 73% Operating EBITDA ANZ % 33% China and Other Asia (3) (4) 0 33% nm UK and US (4) (12) (16) 200% 33% Corporate and Other 3 (8) (10) (12) 25% 20% Group Operating EBITDA % 1 Please refer to the comments in relation to forward looking information which appear on the last page of this release 2 Operating EBITDA is a non-gaap measure and represents earnings before interest, tax, depreciation and amortisation, before non-recurring items and intercompany charges 3 FY16B corporate costs include a significant increase in R&D and additional costs to support business growth

2 Key highlights of the FY15 financial performance are: Substantial growth in a2 Platinum infant formula volume across ANZ and China was a highlight with total infant formula revenue of NZ$41 million; Liquid milk showed continued growth in Australia with revenue increasing 8% to NZ$110 million; and The Company s international business rollout continued with the launch of liquid milk in the USA and repositioning of a2 Milk in the UK to the specialty milk segment. The Company has previously advised an FY16 Group revenue forecast of NZ$230 million. The Company is now budgeting FY16 revenue of NZ$267 million which reflects strong recent financial performance and further expected growth throughout FY16. The key drivers of the budgeted FY16 financial performance include: Continued growth in infant formula sales in both ANZ and China building from the very strong demand for these products evidenced over recent months; Sales from new product launches in ANZ which include whole milk powder (launched June 2015) and ice cream (launch targeted for August 2015); and Expansion of liquid milk sales in the USA business as the roll out continues into further states beyond California. In relation to financing the business plan, the Company intends to maintain a conservative approach with growth funded from cash flows in the first instance. In addition, the Company has short term debt facilities in place to support working capital requirements. Operational Update Infant Formula a more significant strategic growth driver Infant formula is emerging as a significant growth driver for the Company. The growth of a2 Platinum infant formula exceeded expectations in the current year with revenue of NZ$41 million across ANZ and China. The majority of sales occurred within the Australian grocery and pharmacy channels, although the Company believes a proportion may relate to products which are on-sold into China, as is the case with other premium infant formula brands sold in domestic markets. a2 Platinum infant formula was the fastest growing brand in the Australian grocery market during the quarter ending 7 June 2015, notwithstanding achieving ranging in a second major retailer group only part-way through the year, and stock shortages due to higher than expected demand. In response to the growing demand for a2 Platinum infant formula, the Company extended the existing range of three variants to include a fourth product, effective July ANZ consistently strong performer The ANZ business continued to deliver very strong revenue and earnings growth on the prior year, with FY15 returning a record result for the region. Total gross revenue in AUD across all product categories increased by ~44% on the PCP. Operating EBITDA before intercompany charges for FY15 was approximately NZ$30 million. Australian fresh milk sales continued to achieve solid growth of approximately 10% in AUD on the PCP, and achieved a grocery market share of approximately 9.3% (Australian Grocery Weighted Scan MAT) at year end. Further revenue growth was achieved from new products including a full year of a2 Cream and the most recent

3 launch of a2 Milk whole milk powder in limited release within one major retailer in June Looking ahead, the Company is optimistic about the growth prospects for whole milk powder as well as for infant formula. New long term milk supply contracts with key milk suppliers in ANZ have been negotiated to support growing demand moving forward. Asia new model and momentum building through e-commerce platforms As previously advised, the growth of a2 Platinum infant formula within China was impacted by changes in access arrangements for manufacturers and brand owners from ANZ into China during calendar The Company s manufacturing partner Synlait Milk achieved the new form of registration in late September 2014 and shipments recommenced from December. The Company has continued to invest in marketing activity and sales support for distributors during the FY15 year in order to build a solid foundation for future growth in the region. In November 2014, the Company announced changes to the supply and distribution arrangements in China. The Company assumed direct responsibility for the distribution of a2 Platinum with a small local team managing a growing network of distributors. In consequence of these changes and the increasing exposure of the a2 Platinum brand in China, the Company remains very positive regarding the growth prospects in this market. a2 Milk fresh milk sourced from Australia was launched in China in August 2014 in premium supermarkets and through consumer subscriptions and also on JD.com, China's largest online direct sales platform. Whilst the immediate direct sales impact is modest, this initiative will help establish the a2 Milk brand in China and broaden our trial base. To take further advantage of the growing e-commerce and cross-border platforms, the Company also recently launched The a2 Milk Company store on T-mall Global selling Australasian label a2 Platinum infant formula direct to Chinese consumers, and further initiatives will follow. UK repositioned for growth in speciality milk During the financial year, the Company repositioned the a2 Milk brand in the UK into the premium speciality milk segment away from mainstream dairy and is now represented in the majority of supermarket accounts in the UK. The transition from 2-litre to 1-litre and the associated pricing realignment has significantly improved unit gross margins. The introduction of the new format and shift in shelf location was dependent on the timing of retailer reviews and was finally completed during March This timing slowed the rebuilding of momentum in the new format, and sales growth in the second half was slower than planned. Notwithstanding this, the Company is confident in the prospects for the UK market. Following these changes, the Company is also focussed on broadening the product portfolio in the short to medium term with the potential introduction of UHT milk and a2 Platinum infant formula. Following the changes implemented during FY15, the Company is forecasting a reduced funding contribution to this business in FY16.

4 USA launch into California commenced The launch of the a2 Milk brand in the California region commenced in April The Company has made solid progress in building retailer distribution and is on plan to achieve around 65% of retail weighted distribution in Southern California by early August. The focus will then turn to achieving similar distribution in Northern California. Development of the executive team and support structure is almost complete and partnerships have been established with farmers, dairy processors and a network of national sales brokers, all of whom are positive about the prospects of the a2 Milk brand in USA. While it is early in the launch, feedback from retailers and consumers is consistently favourable. After evaluating the early positive trends, the roll-out plans beyond California are now focused on building distribution across a number of national specialty customers, which best align with the brand s healthy and natural positioning. Already the brand is being distributed on a nation-wide basis by two of the largest natural food specialty chains in the USA, Sprouts Farmers Market and The Fresh Market. Intellectual property comprehensive portfolio continuing to build The Company continues to enhance and extend the scope of its comprehensive IP portfolio and provide support for targeted research and development associated with the benefits of the A2 protein and the absence of A1 protein. During the final quarter of FY15, the Company filed four new provisional patent applications relating to health benefits, physical properties and testing methodologies for A1 protein free products. These have relevance for both liquid and powder products. In addition to the publication of the human digestion trial conducted by Curtin University (published in the European Journal of Clinical Nutrition in August 2014), further scientific progress continues to be made. The Company sponsored a human clinical trial in China around the benefits of a2 Milk which was recently completed and publication is expected in FY16. Summary The a2 Milk Company continues to perform strongly, ahead of plan, in its core ANZ business which is delivering significantly increased profits and cash flow; Trading performance in FY15 underpins confidence in the FY16 budget projections; The Company s international growth strategy which targets markets with long term attractive potential remains on track; and The Company continues to review ways to strengthen its capabilities both internally and through external partnerships which will assist in the development of these opportunities. For further information contact: The a2 Milk Company Limited Geoffrey Babidge Managing Director and CEO

5 Forward Looking Information Certain statements in this release constitute forward looking statements and comments about future events, including the Company's expectations about the performance of its businesses as at the date of this release. By their nature, forwardlooking statements involve known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of the Company and which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements. Forward looking statements are provided as a general guide only, and should not be relied on as an indication or guarantee of future performance. No assurances can be given that any forward looking statements referred to in this release will be realised. Any forward looking information speaks only as of the date of this release. Past performance is not indicative of future performance and no guarantee of future returns is implied or given. Nothing contained in this release is a promise, representation, warranty or guarantee as to the past, present or the future performance of the Company. The Company makes no representation, and gives no assurance or guarantee that the occurrence of the events expressed or implied in any forward looking statements in this release will occur or that any assumption that underpins any forward looking information is reasonable. Nothing in this release is a solicitation, invitation, advice or encouragement to buy, sell or hold shares in the Company. About The a2 Milk Company The a2 Milk Company is building a global business based on a differentiated, premium and branded portfolio of dairy and infant formula products supported by an integrated portfolio of intellectual property and a comprehensive body of scientific evidence The a2 Milk Company believes as many people as possible should be able to enjoy the benefits of fresh and natural dairy and are providing a positive alternative to those who find consumption of regular cows' milk challenging The a2 Milk Company has a significant and differentiated premium dairy business in Australia with over 9% value share of the total fresh milk grocery market and more recently has established operations in China, the UK and the USA The a2 Milk Company Limited is dual listed on the NZX and ASX and trades under the codes ATM and A2M respectively About the a2 Milk brand The a2 Milk brand is a naturally occurring cows milk that comes from cows selected to produce only the A2 betacasein protein and not the A1 protein. It is an entirely natural and pure cows milk and not a product of technological process or genetic engineering Originally all domesticated cows produced only the A2 type protein. Owing to a genetic mutation in European herds, another milk protein emerged (A1 protein) and through modern farming practices spread throughout the world The a2 Milk brand is the only cows milk that is free from the A1 protein

For personal use only

For personal use only ASX Code: A2M NZX Code: ATM 17 February 2016 NZX/ASX Market Release Outstanding growth in infant formula drives record results for The a2 Milk Company Full year forecast revised upward Overview - financial

More information

a2 Milk, a2 Platinum and The a2 Milk Company are trade marks of The a2 Milk Company Limited

a2 Milk, a2 Platinum and The a2 Milk Company are trade marks of The a2 Milk Company Limited a2 Milk, a2 Platinum and The a2 Milk Company are trade marks of The a2 Milk Company Limited Agenda 1. Result highlights 2. Group Infant Formula update 3. Regional update 4. Research and development 5.

More information

20 August Geoffrey Babidge. Managing Director & CEO

20 August Geoffrey Babidge. Managing Director & CEO 20 August 2015 Geoffrey Babidge Managing Director & CEO FY15 Result Highlights Revenue growth 40% EBITDA growth 35% 1 Exceptional infant formula result Record Australia result Total revenue of $155.1 million,

More information

FY16 Full Year Results Geoffrey Babidge August a2 Milk, a2 Platinum and The a2 Milk Company are trademarks of The a2 Milk Company Limited

FY16 Full Year Results Geoffrey Babidge August a2 Milk, a2 Platinum and The a2 Milk Company are trademarks of The a2 Milk Company Limited FY16 Full Year Results Geoffrey Babidge August 24 2016 1 a2 Milk, a2 Platinum and The a2 Milk Company are trademarks of The a2 Milk Company Limited Results highlights Financial overview Group infant formula

More information

Investor Presentation

Investor Presentation NZX Code: ATM ASX Code: A2M 3 May 2017 NZX/ASX Market Release Investor Presentation Please find attached a presentation to be given today by The a2 Milk Company Limited at Macquarie s annual Australia

More information

CLSA Investors Forum. Hong Kong September a2 Milk, a2 Platinum and The a2 Milk Company are trademarks of The a2 Milk Company Limited

CLSA Investors Forum. Hong Kong September a2 Milk, a2 Platinum and The a2 Milk Company are trademarks of The a2 Milk Company Limited CLSA Investors Forum Hong Kong 11-12 September 2017 a2 Milk, a2 Platinum and The a2 Milk Company are trademarks of The a2 Milk Company Limited Disclaimer This presentation dated 11 September 2017 provides

More information

FY13 results presentation 29 August 2013 Geoffrey Babidge Managing Director & CEO

FY13 results presentation 29 August 2013 Geoffrey Babidge Managing Director & CEO A2 Corporation FY13 results presentation 29 August 2013 Geoffrey Babidge Managing Director & CEO FY13 result highlights Results ahead of expectations UK and China strategies under way Successful capital

More information

UBS Australasia Conference

UBS Australasia Conference UBS Australasia Conference Sydney 13 November 2017 a2 Milk, a2 Platinum and The a2 Milk Company are trademarks of The a2 Milk Company Limited Disclaimer This presentation dated 13 November 2017 provides

More information

FY17 Full Year Results

FY17 Full Year Results FY17 Full Year Results Geoffrey Babidge August 23, 2017 a2 Milk, a2 Platinum and The a2 Milk Company are trademarks of The a2 Milk Company Limited Contents Result highlights Financial overview Group infant

More information

For personal use only

For personal use only ASX Code: A2M NZX Code: ATM 03 June 2015 NZX/ASX Market Release Investor presentation: UBS Emerging Companies Conference Please find attached a presentation to be shared by The a2 Milk Company Limited

More information

For personal use only. Interim report for the six months ended 31 December 2017

For personal use only. Interim report for the six months ended 31 December 2017 For personal use only Contents 02 CEO s report 08 Directors declaration 09 Auditor s review report 10 Consolidated statement of comprehensive income 11 Consolidated statement of changes in equity 12 Consolidated

More information

ANNUAL MEETING 2016 GEOFFREY BABIDGE MANAGING DIRECTOR & CEO 22 NOVEMBER

ANNUAL MEETING 2016 GEOFFREY BABIDGE MANAGING DIRECTOR & CEO 22 NOVEMBER ANNUAL MEETING 2016 GEOFFREY BABIDGE MANAGING DIRECTOR & CEO 22 NOVEMBER 2016 a2 Milk a2 Platinum and The a2 Milk Company are trademarks of The a2 Milk Company Limited Managing Director s Address Company

More information

For personal use only

For personal use only ASX Announcement Freedom Foods Group Limited (ASX: FNP) FY 2013 Financial Results Freedom Foods Group Limited (FNP) today released the Company s preliminary final results for the full year ended 30 th

More information

Preliminary Unaudited Announcement for the year ended 31 March 2018

Preliminary Unaudited Announcement for the year ended 31 March 2018 QEX Logistics Limited (NXT: QEX) Preliminary Unaudited Announcement for the year ended 31 March 2018 Commentary AUCKLAND, New Zealand, 31 May 2018 The Board of QEX Logistics Limited (NXT: QEX) is pleased

More information

For personal use only

For personal use only Freedom Foods Group Limited Presentation to Morgan's Conference October 2016 Important Information This presentation is provided for information purposes only. The information contained in this presentation

More information

FY17 highlights

FY17 highlights Annual Report 2016 FY17 highlights Total revenue (NZ$ million) $550m - EBITDA 1 (NZ$ million) $141m - Other Infant formula Liquid milk 2.4 11.1 97.3-2014 0.9 41.7 112.5-2015 18.1 214.4 120.3-2016 29.6

More information

8.4 % +56 % 84 % $155m. FY17 highlights. $550m - $141m c - $91m - ANZ EBITDA +83 % Group Revenue. and EBITDA +159%

8.4 % +56 % 84 % $155m. FY17 highlights. $550m - $141m c - $91m - ANZ EBITDA +83 % Group Revenue. and EBITDA +159% Annual Report FY17 highlights Group Revenue +56 % and EBITDA +159% Total revenue (NZ$ million) Other Infant formula Liquid milk $550m - EBITDA 1 (NZ$ million) $141m - a2 Platinum infant formula revenue

More information

For personal use only

For personal use only Welcome to ARBN 158 331 965 This information memorandum has been prepared in connection with the application for admission of to the Official List of the Australian Securities Exchange. No offer of securities

More information

For personal use only

For personal use only 27 April 2016 Market Announcements Office Australian Securities Exchange Level 4 North Tower, Rialto 525 Collins Street Melbourne VIC 3000 ELECTRONIC LODGEMENT Dear Sir or Madam Murray Goulburn Co-operative

More information

For personal use only

For personal use only Tegel Group Holdings Limited FY18 Interim Results Presentation 6 December 2017 1 TEGEL GROUP HOLDINGS FY18 INTERIM RESULTS PRESENTATION Disclaimer This presentation contains summary information about Tegel

More information

Update following MG Capital Structure Workshops

Update following MG Capital Structure Workshops Update following MG Capital Structure Workshops 3rd March 2014 Dear Supplier/Shareholder As we approach the March round of supplier meetings, we wanted to take the opportunity before we meet again, to

More information

ASX ANNOUNCEMENT. Half Year 2019 Results Highlights Presentation

ASX ANNOUNCEMENT. Half Year 2019 Results Highlights Presentation ASX ANNOUNCEMENT Half Year 2019 Results Highlights Presentation I enclose the Half Year 2019 Results Highlights Presentation to be discussed on the Half Year Result 2019 Conference Call scheduled for 11:00am

More information

GEO re-establishes growth momentum

GEO re-establishes growth momentum NZX and Media Release 28 August 2018 Summary UNAUDITED FINANCIAL RESULTS FOR THE YEAR TO 30 JUNE 2018 GEO re-establishes growth momentum Strong revenue growth re-established from March 2018, with June

More information

WELCOME 55 th ANNUAL GENERAL MEETING BLACKMORES LTD 26 OCTOBER 2017

WELCOME 55 th ANNUAL GENERAL MEETING BLACKMORES LTD 26 OCTOBER 2017 WELCOME 55 th ANNUAL GENERAL MEETING BLACKMORES LTD 26 OCTOBER 2017 CHAIRMAN S WELCOME Stephen Chapman Chairman 2 Marcus Blackmore AM Executive Director 3 GUEST SPEAKERS Blackmores Asia 4 CEO S YEAR IN

More information

Interim Results 2019 March 2019

Interim Results 2019 March 2019 Interim Results 2019 March 2019 Disclaimer This presentation may contain forward-looking statements and projections. There can be no certainty of outcome in relation to the matters to which the forward-looking

More information

It s subsidiary CS&Co distributes international cosmetics, fragrances, skincare and haircare brands in New Zealand. Consumer Product Brands

It s subsidiary CS&Co distributes international cosmetics, fragrances, skincare and haircare brands in New Zealand. Consumer Product Brands TIL - Trilogy International Limited (NZX:TIL, ASX:TIL) is a cultivator of essential natural products and home fragrance brands: Trilogy Natural Products, ECOYA and Goodness Natural Beauty Lab in New Zealand

More information

Cover-More Group. UBS Australasia Conference. November 2015

Cover-More Group. UBS Australasia Conference. November 2015 Cover-More Group UBS Australasia Conference November 2015 Executive summary: FY15 overview Cover-More delivered another year of double digit earnings growth, with offshore business growing substantially.

More information

Barry Irvin Executive Chairman Aidan Coleman CEO. Annual General Meeting 27 October 2015

Barry Irvin Executive Chairman Aidan Coleman CEO. Annual General Meeting 27 October 2015 Barry Irvin Executive Chairman Aidan Coleman CEO Annual General Meeting 27 October 2015 Agenda 2015 Annual Report Executive Chairman s Report Chief Executive Officer s Report Questions Approval of Remuneration

More information

For personal use only

For personal use only NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES TRANSFORMATIVE AGREEMENT TO ACQUIRE NULAC FOODS AND INTEREST IN DAIRY PROCESSING FACILITY, PLACEMENT AND SHARE PURCHASE PLAN TO BE UNDERTAKEN Bubs to

More information

Half year result. 26 August 2016

Half year result. 26 August 2016 2016 Half year result 26 August 2016 Alison Watkins Group Managing Director Martyn Roberts Group Chief Financial Officer Barry O Connell MD Australian Beverages Agenda Group Result Summary Shareholder

More information

Half Year Report For the six months to 30 September 2017

Half Year Report For the six months to 30 September 2017 Half Year Report For the six months to 30 September 2017 OPERATIONS REPORT 30 September 2017 OVERVIEW Blis Technologies Limited (Company) was formed to commercialise BLIS advanced probiotic bacteria in

More information

FONTERRA INTERIM RESULTS 2014

FONTERRA INTERIM RESULTS 2014 FONTERRA INTERIM RESULTS 2014 Market Briefing FONTERRA CO-OPERATIVE GROUP LIMITED Overview John Wilson Chairman 2 Working Area Safee Copy Frame. This denotes working area and must be deleted before final

More information

For personal use only

For personal use only ABN 85 003 622 866 GPO Box 5015, Sydney NSW 2001 Level 1, 160 Pitt Street Mall, Sydney NSW 2000 ASX Appendix 4E Preliminary Final Report 31 st July 2015 Lodged with the ASX under Listing Rule 4.3A Contents

More information

Serko Limited ASX Small and Mid Cap Conference, 6 September 2018

Serko Limited ASX Small and Mid Cap Conference, 6 September 2018 Serko Limited ASX Small and Mid Cap Conference, 6 September 2018 1 CEO PRESENTATION Darrin Grafton Chief Executive Officer 2 PRESENTATION OUTLINE About Serko Strategy Overview FY18 Results Overview Investment

More information

Bega Cheese Annual General Meeting. Barry Irvin Executive Chairman Paul van Heerwaarden CEO

Bega Cheese Annual General Meeting. Barry Irvin Executive Chairman Paul van Heerwaarden CEO Bega Cheese Annual General Meeting Barry Irvin Executive Chairman Paul van Heerwaarden CEO Agenda 2017 Annual Report Executive Chairman s Report Chief Executive Officer s Report Questions Approval of Remuneration

More information

John Wilson - Chairman. Fonterra Co-operative Group Ltd. #

John Wilson - Chairman. Fonterra Co-operative Group Ltd. # John Wilson - Chairman # Key highlights FORECAST CASH PAYOUT $6.12 Forecast Farmgate Milk Price lifted to $5.80 kgms. The full year dividend forecast remains at 32 cps VOLUME: MILK COLLECTIONS 6% Record

More information

FONTERRA ANNUAL RESULTS FONTERRA CO-OPERATIVE GROUP LIMITED Fonterra Co-operative Group Ltd.

FONTERRA ANNUAL RESULTS FONTERRA CO-OPERATIVE GROUP LIMITED Fonterra Co-operative Group Ltd. FONTERRA ANNUAL RESULTS 2013 FONTERRA CO-OPERATIVE GROUP LIMITED 1 John Wilson Chairman 2 Key highlights FARMGATE MILK PRICE $5.84kgMS DIVIDEND 32 cps FINAL CASH PAYOUT $6.16 NET PROFIT EARNINGS PER SHARE

More information

Introductions. Chairman s comments. CEO presentation. General discussion / Q&A. Formal business of the meeting. Close and afternoon tea

Introductions. Chairman s comments. CEO presentation. General discussion / Q&A. Formal business of the meeting. Close and afternoon tea Introductions Chairman s comments CEO presentation General discussion / Q&A Formal business of the meeting Close and afternoon tea 2 Chairman Executive Director CS&Co Representative Director Independent

More information

For personal use only

For personal use only JATENERGY LIMITED ABN 31 122 826 242 ASX APPENDIX 4D RESULTS FOR ANNOUNCEMENT TO THE MARKET FOR THE SIX MONTHS ENDED 31 DECEMBER 2018 The following information should be read in conjunction with both the

More information

For personal use only

For personal use only ASX:SKF SKYFII QUARTERLY BUSINESS REVIEW Q2 FY2019 Q2 FY2019 Highlights Total Operating Revenues for the December-ended quarter, Q2 FY2019, of $2.4m, up 7% on prior quarter, representing a strong continuation

More information

Serko Limited FY19 Interim Results for the period ended 30 September 2018

Serko Limited FY19 Interim Results for the period ended 30 September 2018 Serko Limited FY19 Interim Results for the period ended 30 September 2018 1 Disclaimer This presentation has been prepared by Serko Limited. All information is current at the date of this presentation,

More information

FY2018 Full Year Roadshow Presentation. Barry Irvin Executive Chairman Paul van Heerwaarden CEO Colin Griffin CFO

FY2018 Full Year Roadshow Presentation. Barry Irvin Executive Chairman Paul van Heerwaarden CEO Colin Griffin CFO FY2018 Full Year Roadshow Presentation Barry Irvin Executive Chairman Paul van Heerwaarden CEO Colin Griffin CFO Key Message Creating the Great Australian Food Company Bega Foods integration complete Peanut

More information

Agenda. Welcome. Chairman s address. CEO review. General business. Refreshments

Agenda. Welcome. Chairman s address. CEO review. General business. Refreshments Important Notice This document contains summary information about Mercer Group Limited (MGL) as at 29 November 2018. The information is subject to change without notice and does not purport to be complete

More information

Tegel Group Holdings Limited

Tegel Group Holdings Limited Tegel Group Holdings Limited FY17 Full Year Results Presentation 27 June 2017 1 TEGEL GROUP HOLDINGS FY17 RESULTS PRESENTATION Disclaimer This presentation contains summary information about Tegel Group

More information

For personal use only

For personal use only PRELIMINARY FULL YEAR REPORT ANNOUNCEMENT The a2 Milk Company Limited For the year ended 30 June 2016 Preliminary full year (12 month) report on consolidated results (including the results for the previous

More information

1H FY19 RESULTS PRESENTATION 25 February 2019

1H FY19 RESULTS PRESENTATION 25 February 2019 RELIANCE WORLDWIDE CORPORATION LIMITED ACN 610855877 1H FY19 RESULTS PRESENTATION 25 February 2019 INVESTOR PRESENTATION 1H FY19 RESULTS PAGE 0 Important Notice This presentation contains general information

More information

Full Year. Results. 21 February 2019 For the year ended 31 December iress.com

Full Year. Results. 21 February 2019 For the year ended 31 December iress.com 2018 Full Year Results 21 February 2019 For the year ended 31 December 2018 1 Agenda Who we are 3 2018 results 8 Segment overview 13 Financial information 22 2019 Outlook 27 Andrew Walsh Managing Director

More information

Preliminary Results FY17

Preliminary Results FY17 Preliminary Results FY17 25 th May 2017 Forward looking statements Forward-Looking Statements INCLUDED IN THIS PRESENTATION ARE FORWARD-LOOKING MANAGEMENT COMMENTS AND OTHER STATEMENTS THAT REFLECT MANAGEMENT

More information

2015 ANNUAL RESULTS SEPTEMBER 2015 JOHN WILSON, CHAIRMAN THEO SPIERINGS, CEO LUKAS PARAVICINI, CFO

2015 ANNUAL RESULTS SEPTEMBER 2015 JOHN WILSON, CHAIRMAN THEO SPIERINGS, CEO LUKAS PARAVICINI, CFO 2015 ANNUAL RESULTS SEPTEMBER 2015 JOHN WILSON, CHAIRMAN THEO SPIERINGS, CEO LUKAS PARAVICINI, CFO Forward Looking Statements This presentation contains forward looking statements, and forecasts, including

More information

FY17 Annual Results Announcement

FY17 Annual Results Announcement FY17 Annual Results Announcement Ainsworth Game Technology Limited www.agtslots.com.au Disclaimer IMPORTANT NOTICE This presentation has been prepared by Ainsworth Game Technology Limited ACN 068 516 665

More information

FY18 Results Presentation Bravura Solutions Limited. 28 August 2018

FY18 Results Presentation Bravura Solutions Limited. 28 August 2018 FY18 Results Presentation Bravura Solutions Limited 28 August 2018 Important notice and disclaimer The information contained in this document (including this notice) and discussed at this presentation

More information

For personal use only

For personal use only FY14 RESULTS John Croll Chief Executive Officer Nimesh Shah Chief Financial Officer AGENDA OVERVIEW OF FY14 RESULT FINANCIAL PERFORMANCE FY15 OUTLOOK GROWTH STRATEGY Q&A JOHN CROLL NIMESH SHAH JOHN CROLL

More information

Nufarm Interim Results

Nufarm Interim Results Nufarm Interim Results 6 months to January 31, 2018 March 21, 2018 1 Disclaimer General This presentation has been prepared by Nufarm Limited. The information contained in this presentation is for informational

More information

Company Directory 1. Chairman s Report 2. Managing Director s Report 3. Directors Responsibility Statement 6. Audit Report 7

Company Directory 1. Chairman s Report 2. Managing Director s Report 3. Directors Responsibility Statement 6. Audit Report 7 A2 Corporation Limited Annual Report 30 June 2012 Contents For the year ended 30 JUNE 2012 CONTENTS PAGE Directory 1 Chairman s Report 2 Managing Director s Report 3 Directors Responsibility Statement

More information

Update on Murray Goulburn s Capital Structure Proposal

Update on Murray Goulburn s Capital Structure Proposal Update on Murray Goulburn s Capital Structure Proposal Dear Supplier/Shareholder August 2014 Discussion Paper 3 Re: Update on MG s Capital Structure Recently your Board and management team concluded Round

More information

For personal use only

For personal use only Annual General Meeting 2018 CEO Presentation 29 November 2018 ASX: SKF www.skyfii.io Important Notice and Disclaimer 2 This presentation has been prepared by Skyfii Limited (ACN 009 264 699) (Skyfii or

More information

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED HALF YEAR FY14 RESULTS PRESENTATION WEDNESDAY 30 APRIL 2014

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED HALF YEAR FY14 RESULTS PRESENTATION WEDNESDAY 30 APRIL 2014 AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED HALF YEAR FY14 RESULTS PRESENTATION WEDNESDAY 30 APRIL 2014 Important Notice The material in this presentation is of general information about API s activities

More information

Murray Goulburn announces revised forecast, appoints interim CEO

Murray Goulburn announces revised forecast, appoints interim CEO Supplier briefing Murray Goulburn announces revised forecast, appoints interim CEO Wednesday 27 April 2016 Murray Goulburn Co-operative Co. Limited ABN 23 004 277 089 Freshwater Place, Level 15, 2 Southbank

More information

Disclaimer: Forward Looking Statements

Disclaimer: Forward Looking Statements 9 August 2018 Disclaimer: Forward Looking Statements This presentation/announcement may contain forward looking statements with projections regarding, among other things, the Group s strategy, revenues,

More information

FY16 full year results and FY17 outlook presentation Supplier meetings. September 2016

FY16 full year results and FY17 outlook presentation Supplier meetings. September 2016 FY16 full year results and FY17 outlook presentation Supplier meetings September 2016 Introduction Agenda 1. Current situation 2. Milk Supply Support Package 3. Trends impacting FY17 4. FY16 results 5.

More information

CSL Limited Full Year Results 15 August CEO Paul Perreault CFO David Lamont

CSL Limited Full Year Results 15 August CEO Paul Perreault CFO David Lamont CSL Limited 2018 Full Year Results 15 August 2018 CEO Paul Perreault CFO David Lamont Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials,

More information

ASX ANNOUNCEMENT DATE: 22 February 2017 Attached is the Presentation regarding Pact s Half year Financial Results for the half year ended 31 December 2016. The Presentation will occur at 10am (Melbourne

More information

Company Results Half Year ended 4 January 2009

Company Results Half Year ended 4 January 2009 Michael Luscombe Chief Executive Officer Tom Pockett Finance Director Company Results Half Year ended 4 January 2009 Highlights Financial Half Year 09 This is a strong result reflecting increasing customer

More information

Performance summary FOR THE YEAR ENDED 31 MARCH 2015

Performance summary FOR THE YEAR ENDED 31 MARCH 2015 Performance summary FOR THE YEAR ENDED 31 MARCH 2015 Constant currency NZ $000 2015 2014 Variance % Variance % 4 Sales revenue 96,349 96,720-0.4% 0.7% EBITDA 1 12,682 11,286 12.4% 13.4% NPAT 3 5,690 4,708

More information

Inghams Group Limited. FY2018 Results Presentation

Inghams Group Limited. FY2018 Results Presentation Inghams Group Limited FY2018 Results Presentation 22 AUGUST 2018 Important notice and disclaimer Disclaimer The material in this presentation is general background information about the activities of Inghams

More information

Sigma Pharmaceuticals Limited

Sigma Pharmaceuticals Limited Sigma Pharmaceuticals Limited Results Presentation for the Full Year ended 31 January 2013 Mark Hooper CEO& Managing Director Jeff Sells Chief Financial Officer 14 March 2013 Important notice The material

More information

METHVEN LIMITED. Results for announcement to the market

METHVEN LIMITED. Results for announcement to the market METHVEN LIMITED Results for announcement to the market Reporting Period 6 months ended 31 December 2016 Previous Reporting Period 9 months ended 31 December 2015 Amount (NZD 000s) Percentage change Sales

More information

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED FULL YEAR FY12 RESULTS PRESENTATION THURSDAY 25 OCTOBER 2012

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED FULL YEAR FY12 RESULTS PRESENTATION THURSDAY 25 OCTOBER 2012 AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED FULL YEAR FY12 RESULTS PRESENTATION THURSDAY 25 OCTOBER 2012 1 Important notice The material in this presentation is of general information about API s activities

More information

For personal use only

For personal use only ASX and Media Release 16 August 2018 GALE Pacific delivers to top end of guidance with FY18 PBT $12.5m GALE Pacific Limited (ASX: GAP) is pleased to announce its financial results for the full year ended

More information

2017 FULL YEAR RESULTS

2017 FULL YEAR RESULTS 2017 FULL YEAR RESULTS ESTABLISHING LEADING POSITIONS IN NEW GROWTH SECTORS Malcolm Bundey Managing Director and CEO Richard Betts Chief Financial Officer 16 August 2017 Pact Group Holdings Ltd ABN: 55

More information

RESTAURANT BRANDS DELIVERS RECORD PROFIT

RESTAURANT BRANDS DELIVERS RECORD PROFIT RESTAURANT BRANDS NEW ZEALAND LIMITED 17 April 2018 NZX/ASX RESTAURANT BRANDS DELIVERS RECORD PROFIT $NZm 2018 2017 Change ($) Change (%) Total Group Sales 740.8 497.2 +243.6 +49.0 Group NPAT (reported)

More information

ANNUAL REPORT GROWING THROUGH CAPABILITY

ANNUAL REPORT GROWING THROUGH CAPABILITY 2017 ANNUAL REPORT GROWING THROUGH CAPABILITY CONTENTS PG04 PG06 PG56 PG67 PG69 PG70 PG71 PG72 PG73 PG74 PG111 PG112 PG118 PG120 Chairman s letter Managing director s review of operations Directors report

More information

For personal use only

For personal use only CSL Limited 2017 Half Year Results 15 February 2017 CEO Paul Perreault CFO David Lamont Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials,

More information

Paul Maguire Philip Bennett Paul Witheridge Managing Director Chief Financial Officer Chief Financial Officer

Paul Maguire Philip Bennett Paul Witheridge Managing Director Chief Financial Officer Chief Financial Officer McPherson s Limited Results for the year to 30 June 2011 Paul Maguire Philip Bennett Paul Witheridge Managing Director Chief Financial Officer Chief Financial Officer McPherson s Limited McPherson s Limited

More information

For personal use only. Lovisa Holdings Limited 2019 HALF YEAR

For personal use only. Lovisa Holdings Limited 2019 HALF YEAR Lovisa Holdings Limited 2019 HALF YEAR SHANE FALLSCHEER CHRIS LAUDER MANAGING DIRECTOR CHIEF FINANCIAL OFFICER Some of the information contained in this presentation contains forward - looking statements

More information

Tegel Group Holdings Limited

Tegel Group Holdings Limited Tegel Group Holdings Limited FY17 Interim Results Presentation 15 December 2016 TEGEL GROUP HOLDINGS LIMITED FY17 INTERIM RESULTS 1 Disclaimer This presentation contains summary information about Tegel

More information

Welcome to the 50th Annual General Meeting of Blackmores Limited

Welcome to the 50th Annual General Meeting of Blackmores Limited Welcome to the 50th Annual General Meeting of Blackmores Limited Year in Review Christine Holgate CEO & Managing Director 2 10 th year of record sales and profit Group Sales up 11% to $261m Fourth Quarter

More information

Anpario plc (AIM: ANP) Financial and operational highlights. Financial highlights. Operational highlights

Anpario plc (AIM: ANP) Financial and operational highlights. Financial highlights. Operational highlights Interim Report 2017 Anpario plc (AIM: ANP) 19 September 2017 Anpario plc, the international producer and distributor of natural animal feed additives for animal health, nutrition and biosecurity is pleased

More information

Annual Results 2017: Quality of business improved due to brand investment, international expansion, and product innovation

Annual Results 2017: Quality of business improved due to brand investment, international expansion, and product innovation Arla Foods amba Aarhus, Denmark INVESTOR ANNOUNCEMENT 21-02-2018 Annual Results 2017: Quality of business improved due to brand investment, international expansion, and product innovation Strong performance

More information

For personal use only

For personal use only Investor Presentation Half Year Results to 31 December 2016 24 February 2017 PETER CAUGHEY, CEO & MANAGING DIRECTOR 1 Agenda Overview Financials Business conditions, strategy and outlook 2 Overview 1H17

More information

25 February 2019 The PAS Group Limited H1 FY2019 Results Briefing

25 February 2019 The PAS Group Limited H1 FY2019 Results Briefing 25 February 2019 The PAS Group Limited H1 FY2019 Results Briefing ABN 25 169 477 463 H1 FY2019 Results Summary Sales up 9.9% to $143.0 million Online sales up 11.0% Wholesale sales up 32.1% Retail sales

More information

NUPLEX INDUSTRIES LIMITED RESULTS PRESENTATION FOR THE YEAR ENDED 30 JUNE 2012 PRESENTATION AGENDA

NUPLEX INDUSTRIES LIMITED RESULTS PRESENTATION FOR THE YEAR ENDED 30 JUNE 2012 PRESENTATION AGENDA NUPLEX INDUSTRIES LIMITED RESULTS PRESENTATION FOR THE YEAR ENDED 30 JUNE 2012 17 AUGUST 2012 Emery Severin, Chief Executive Officer Ian Davis, Chief Financial Officer PRESENTATION AGENDA 1. Group Overview

More information

For personal use only

For personal use only INVESTOR UPDATE DECEMBER 2017 JATenergy Limited DISCLAIMER This presentation has been prepared by JATenergy Limited (JAT). The information contained in this presentation is for information purposes only

More information

Dean Foods. May 2015

Dean Foods. May 2015 Dean Foods May 2015 1 Forward-Looking Statements Some of the statements made in this presentation are forward-looking and are made pursuant to the safe harbor provision of the Private Securities Litigation

More information

MEDIA RELEASE JUST GROUP S FIRST HALF NET PROFIT UP 9.0% ANNOUNCES SOUTH AFRICAN JOINT VENTURE AND OFF-MARKET SHARE BUY-BACK

MEDIA RELEASE JUST GROUP S FIRST HALF NET PROFIT UP 9.0% ANNOUNCES SOUTH AFRICAN JOINT VENTURE AND OFF-MARKET SHARE BUY-BACK 7 March 2007 MEDIA RELEASE JUST GROUP S FIRST HALF NET PROFIT UP 9.0% ANNOUNCES SOUTH AFRICAN JOINT VENTURE AND OFF-MARKET SHARE BUY-BACK Just Group today announced a net profit of $39.7 million for the

More information

Lion s 2016 Taxes Paid Report

Lion s 2016 Taxes Paid Report Lion s 2016 Taxes Paid Report CFO Statement On behalf of the Lion Board, we are pleased to share with you Lion s Taxes Paid Report for the financial year ending 30 September 2016. At Lion, our core purpose

More information

For personal use only

For personal use only RELIANCE WORLDWIDE CORPORATION LIMITED ACN 610855877 www.rwc.com FY2016 RESULTS PRESENTATION 29 August 2016 Important notice This presentation contains general information about s activities at the date

More information

A N N U A L S H A R E H O L D E R S M E E T I N G N O V E M B E R

A N N U A L S H A R E H O L D E R S M E E T I N G N O V E M B E R A N N U A L S H A R E H O L D E R S M E E T I N G N O V E M B E R 2 0 1 7 AGENDA Welcome Chairman s review Managing Director s review Ordinary business and resolutions 2 CHAIRMAN S REVIEW Successful IPO

More information

Half Year 18 Presentation and Business Update. 28 November 2017

Half Year 18 Presentation and Business Update. 28 November 2017 Half Year 18 Presentation and Business Update 28 November 2017 Important information The information in this presentation is of a general nature and does not constitute financial product advice, investment

More information

Sysco 2Q16 Earnings Results. February 1, 2016

Sysco 2Q16 Earnings Results. February 1, 2016 Sysco 2Q16 Earnings Results February 1, 2016 Forward-Looking Statements Statements made in this presentation or in our earnings call for the second quarter of fiscal 2016 that look forward in time or that

More information

Directors Report to Shareholders For the 28 Weeks ended 11 September 2017 (1H 2018)

Directors Report to Shareholders For the 28 Weeks ended 11 September 2017 (1H 2018) RESTAURANT BRANDS NEW ZEALAND LIMITED Directors Report to Shareholders For the 28 Weeks ended 11 September 2017 (1H 2018) Key Points Total Group Sales ($m) 386.1 256.2 +129.9 +50.7 Group NPAT (reported)

More information

Dairy Crest Group plc Preliminary results For the year ended 31 March 2018

Dairy Crest Group plc Preliminary results For the year ended 31 March 2018 Dairy Crest Group plc Preliminary results For the year ended 31 March 2018 DISCLAIMER The information contained in this presentation, which has is personal to the recipient, has not been independently

More information

(RBD) INVESTOR PRESENTATION

(RBD) INVESTOR PRESENTATION RESTAURANT BRANDS NEW ZEALAND LIMITED (RBD) INVESTOR PRESENTATION MAY 2018 RUSSEL CREEDY GROUP CHIEF EXECUTIVE OFFICER GRANT ELLIS GROUP CHIEF FINANCIAL OFFICER 1 OUTLINE Restaurant Brands 101 FY18 Results

More information

1H18 Results Presentation Sid Takla Interim Chief Executive Officer Lyndal York Chief Financial Officer

1H18 Results Presentation Sid Takla Interim Chief Executive Officer Lyndal York Chief Financial Officer 1H18 Results Presentation Sid Takla Interim Chief Executive Officer Lyndal York Chief Financial Officer 21 August 2018 Important Notice and Disclaimer This presentation has been prepared by Asaleo Care

More information

For personal use only

For personal use only INVESTOR UPDATE NOVEMBER 2017 Jatenergy Limited DISCLAIMER This presentation has been prepared by Jatenergy Limited (JAT). The information contained in this presentation is for information purposes only

More information

For personal use only ANNUAL GENERAL MEETING CEO PRESENTATION 21 NOVEMBER 2017

For personal use only ANNUAL GENERAL MEETING CEO PRESENTATION 21 NOVEMBER 2017 ANNUAL GENERAL MEETING CEO PRESENTATION 21 NOVEMBER 2017 2 COMPANY OVERVIEW 3 PERFORMANCE UPDATE 7 MARKET OPPORTUNITY 12 OPERATING & FINANCIAL HIGHLIGHTS 15 SUMMARY & OUTLOOK 18 3 COMPANY OVERVIEW Company

More information

ANNUAL FINANCIAL RESULTS FOR THE YEAR ENDED 31 JULY 2017

ANNUAL FINANCIAL RESULTS FOR THE YEAR ENDED 31 JULY 2017 ANNUAL FINANCIAL RESULTS FOR THE YEAR ENDED 31 JULY 2017 CONTENTS DIRECTORS STATEMENT 1 INCOME STATEMENT 2 STATEMENT OF COMPREHENSIVE INCOME 3 STATEMENT OF FINANCIAL POSITION 4 STATEMENT OF CHANGES IN

More information

For personal use only

For personal use only 2018 Annual General Meeting of Helloworld Travel Limited 15 November 2018 1 Disclaimer The information contained in these materials or discussed at the presentation is not intended to be an offer for subscription,

More information

Synlait Milk Limited Interim Report 2014

Synlait Milk Limited Interim Report 2014 4 3 2 1 ON Synlait Milk Limited Interim Report 2014 1 LEADERSHIP UPDATE... 2 GROWTH INITIATIVES... 3 FINANCIAL PERFORMANCE... 4 FINANCIAL STATEMENTS... TRACK page 2 I Synlait Milk Limited Interim Report

More information

Monash IVF Group. FY16 Results Presentation 26 August 2016

Monash IVF Group. FY16 Results Presentation 26 August 2016 Monash IVF Group FY16 Results Presentation 26 August 2016 Disclaimer The presentation has been prepared by Monash IVF Group Limited (ACN 169 302 309) ( MVF ) (including its subsidiaries, affiliates and

More information